United States · FDA National Drug Code directory
ENCELTO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82958-501_943731b7-6b10-4527-ac10-53a5a5e3a5ee
- Product NDC
- 82958-501
- Form
- IMPLANT
- Composition / generic term
- revakinagene taroretcel-lwey
- Labeler
- Neurotech Pharmaceuticals, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250312
- Source listing expiry
- 20271231
Source-listed ingredients
- REVAKINAGENE TARORETCEL-LWEY — 440000 [arb'U]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CAPSULE in 1 CONTAINER (82958-501-01) / 1 IMPLANT in 1 CAPSULE · 82958-501-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →